White House offers new comments on cannabis rescheduling, hemp

white house over cannabis leaves representing trump cannabis rescheduling

The White House has reaffirmed President Donald Trump’s support for cannabis reforms as questions swirl around rescheduling and the future of hemp-derived products. However, the administration stopped short of confirming whether either issue will be resolved anytime soon.

RELATED: What the blue wave means for cannabis reform

GreenState asked the White House whether Trump remains confident that all cannabis will be rescheduled. While the administration did not offer a definitive answer, White House spokeswoman Allison Schuster reiterated the president’s support for reform.

“President Trump has made his position on hemp and cannabis abundantly clear, most recently in a December executive order and April TRUTH Social post. This position builds on the President’s 2018 Farm Bill, which authorized the production of hemp, and his support for Florida Amendment 3 in 2024,” Schuster wrote in an email.

Schuster was referring to Trump’s executive order directing federal officials to expedite the rescheduling process initiated under former President Joe Biden. The social media post in question likely dates to April 23, 2026, and calls on Congress to ensure Americans can continue to access full-spectrum CBD products. 

Although the inquiry focused on marijuana rescheduling, Schuster also addressed hemp policy. Many full-spectrum CBD products could lose their legal status under federal law on Dec. 11, when restrictions enacted last year are scheduled to take effect.

“The only interest guiding the Trump administration’s decision-making is the best interest of the American people, and the Administration continues to explore a Gold Science Standard-based framework on hemp to expand treatment options for American veterans and patients.”

RELATED: Hemp ban could wipe out two-thirds of businesses, new report finds

It remains to be seen whether Congress can pass meaningful legislation on hemp before the ban. It appears another delay may be the path of least resistance, with some lawmakers floating a provision to a broader spending bill still in progress.

State-legal medical marijuana was moved to Schedule III earlier this year, but rescheduling of all cannabis (namely, adult-use) remains unresolved. DEA Administrative Law Judge Derek Julius has yet to issue his recommendation following hearings that concluded in July. DEA Administrator Terrance Cole will determine whether to finalize the proposed rule.

The White House’s latest comments signal continued support for reform but offer little clarity on when or if that support will translate to policy. With a looming deadline on hemp and a question mark around rescheduling, the cannabis community sits in a familiar position: waiting for Washington to act. 

rachelle gordon

Rachelle Gordon is the editor of GreenState. An award-winning cannabis journalist, Emerald Cup judge, and Budist critic, Rachelle began her weed writing journey in 2015. She has been featured in High Times, CannabisNow, Beard Bros, MG, Skunk, and many others. Rachelle was the recipient of the Cannabis Journalist of the Year award at the 2025 Emjays and the Community Cultivator trophy at the 2024 Women's Canna Awards. She has a particular interest in how cannabinoids may benefit people living with neurological conditions and autism spectrum disorder. Follow Rachelle on Instagram @rachellethewriter